Dr. Adel Al-Hazzani has been working as an associate professor at King Saud University’s College of Medicine in Riyadh since January 2019.
Al-Hazzani has a long academic career teaching at different medical colleges across Ƶ. He graduated from King Khaled University (KKU) in Abha in 2001 with a bachelor’s degree in medicine. Al-Hazzani proceeded to Canada to complete a neurology residency program at McGill University in Montreal.
He spent the years between 2008 and 2010 at Harvard University in Massachusetts, US, doing a medicine fellowship in vascular neurology and interventional neuroradiology.
Al-Hazzani has been teaching neurology at KKU since 2017. He also served as the chairman of KKU’s clinical biochemistry department and vice dean of clinical affairs at the Medicine College, and dean of the Pharmacy College during this stint with KKU.
Al-Hazzani served as a consultant at the King Abdul Aziz Medical City from June 2016 to September 2017.
Moreover, he served as the acting president of the Saudi Stroke Association in Riyadh from January 2018 until he became president in December 2019.
Recently, the Saudi Health Ministry initiated a program, in collaboration with Boehringer Ingelheim, to assign dedicated hospitals to manage stroke patients across different geographic zones, with Riyadh being the first phase.
At an event organized as part of the initiative, Al-Hazzani said: “Across the Kingdom, around 25,000 stroke cases are reported annually, and research suggests that the disease will continue to rise between 50 to 60 percent in the coming years. This is especially important as it sheds light on the importance of establishing dedicated stroke units in hospitals around the Kingdom.”
